On September 8, 2022 Calidi Biotherapeutics, Inc. (Calidi), a clinical-stage biotechnology company that is pioneering allogeneic cell-based platforms to revolutionize oncolytic virus therapies, reported that senior management will present a company overview at two upcoming investor conferences (Press release, Calidi Biotherapeutics, SEP 8, 2022, View Source [SID1234619279]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

SALT New York 2022 on Monday, September 12, 2022 at 7:00 a.m. PT / 10:00 a.m ET; and
Baird 2022 Global Healthcare Conference on Tuesday, September 13, 2022 at 11:35 a.m. PT / 2:35 p.m. ET.